Mitchell Rosner headshot
MR

Mitchell H. Rosner

Professor
Unit: School of Medicine
Department: Department of Medicine, Nephrology Division
Office location and address
Kidney Center Clinic
1335 Lee St
Charlottesville, Virginia 22903
Education
Medical College of Georgia, 1996, MD
Residency, Internal Medicine, University of Virginia
Fellowship, Nephrology, University of Virginia
Biography

Dr. Mitchell Rosner is a nephrologist with a clinical focus on fluid and electrolyte disorders, acute kidney injury and polycystic kidney disease (PKD). He is a principal investigator on several trials studying novel compounds for the treatment of PKD and leads a regional PKC clinical center. 

Dr. Rosner is the Henry Mulholland Professor of Medicine and chair of the University of Virginia Department of Medicine. He is board-certified in both internal medicine and nephrology.

A native of Roslyn, N.Y., Dr. Rosner completed his undergraduate studies at Harvard University and earned his medical degree from Harvard Medical School and the Medical College of Georgia. He completed his residency and fellowship training in nephrology at the University of Virginia, joining the UVA faculty in 2005.

Outside of his role at UVA, Dr. Rosner enjoys spending time outside with his family, including his three children.

A Double-blind Randomized Parallel Group Study of the Efficacy and Safety of Tesevatinib in Subjects with Autosomal Dominant Polycystic Kidney Disease
Source: Kadmon Corporation, LLC
December 01, 2017 – November 30, 2021
MD-INMD-NE Otsuka Tolvaptan Polycystic Kidney Disease (OPC-41061)
Source: Otsuka Pharmaceutical Development & Commercializat
September 01, 2014 – January 31, 2020
MD-INMD-NE Otsuka Tolvaptan Polycystic Kidney Disease (OPC-41061); Protocols 156-13-210
Source: Otsuka Pharmaceutical Development & Commercializat
November 01, 2014 – October 31, 2017
Mid Atlantic Nephrology Young Investigator's Research Forum
Source: Amgen Inc.
October 11, 2006 – December 31, 2016
MD-INMD NE179 Mid-Atlantic Nephrology Young Investigator's Research Forum
Source: Amgen Inc.
August 07, 2007 – December 31, 2016
Clinical Activity and Pharmacokinetics of Bosutinib (PF-05208763)
Source: Pfizer Pharmaceutical Labs.
November 28, 2011 – November 27, 2014
  • 2015-2018 Best Doctors in America® List